Information for ruling 600013517
This section is Advance Tariff Ruling
- Start date
- 03 Sep 2025
- Expiry date
- 02 Sep 2028
- Commodity code
- 3004900000 (opens in new tab)
- Description
- radiopharmaceutical containing the radioactive isotope Lutetium-177 single patient dose, administered intravenously, via the vial Physical form: liquid Use: in clinical trials for assessment of its performance as a therapeutic medicine in humans Packaging :a vial held within shielded container to give protection against the radioactivity
- Keywords
-
- PUT UP IN MEASURED DOSES
- AGAINST CANCER
- LUTETIUM
- FOR THERAPEUTIC USE
- PHARMACEUTICAL PRODUCTS
- IN PHIALS
- Justification
- Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3004 - Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale GIR 5b has been used to identify the type of packaging – a vial held within shielded container to give protection against the radioactivity GIR 6 has been used to classify the goods to subheading level 300490 – Other than elsewhere specified Also classified in accordance with: HSEN to 3004